Clinical Trial Update: Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of dexpramipexole (KNS-760704) in hypereosinophilic syndrome; current status is not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypereosinophilic Syndrome

Drugs mentioned

• Dexpramipexole (dexpramipexole)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Hypereosinophilic Syndrome | Phase 2 | Status: UNKNOWN